Literature DB >> 11703367

Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.

S M Trigwell1, P M Radford, S R Page, A C Loweth, R F James, N G Morgan, I Todd.   

Abstract

The generation of an autoimmune response against islet beta-cells is central to the pathogenesis of type 1 diabetes mellitus, and this response is driven by the stimulation of autoreactive lymphocytes by components of the beta-cells themselves. Reactive oxygen species (ROS) have been implicated in the beta-cell destruction which leads to type 1 diabetes and may modify beta-cell components so as to enhance their immunogenicity. We investigated the effects of oxidation reactions catalysed by copper or iron on the major beta-cell autoantigen glutamic acid decarboxylase (GAD). Lysates of purified rat islets were exposed to copper or iron sulphate with or without hydrogen peroxide or ascorbic acid. Immunostaining showed that these treatments generated high molecular weight covalently linked aggregates containing GAD. These are not formed by intermolecular disulphide bonds between cysteine residues since they cannot be resolved into monomeric form when electrophoresed under extreme reducing conditions. There was no modification of insulin or pro-insulin by ROS. The same oxidative changes to GAD could be induced in viable islet cells treated with copper sulphate and hydrogen peroxide, and thus the modifications are not an artefact of the catalysed oxidation of cell-free lysates. Sera from patients with type 1 diabetes and stiffman syndrome containing GAD antibodies reacted predominantly with the highest molecular weight modified protein band of GAD: normal human sera did not precipitate GAD. Thus, oxidatively modified aggregates of GAD react with serum antibodies of type 1 diabetes patients and some SMS patients: this is consistent with oxidative modifications of autoantigens being relevant to the pathogenesis of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703367      PMCID: PMC1906190          DOI: 10.1046/j.1365-2249.2001.01653.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress.

Authors:  H M Kubisch; J Wang; T M Bray; J P Phillips
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

Review 2.  Autoimmune diabetes: the role of the islets of Langerhans.

Authors:  F Homo-Delarche; C Boitard
Journal:  Immunol Today       Date:  1996-10

3.  Heteromers of glutamate decarboxylase isoforms occur in rat cerebellum.

Authors:  S N Sheikh; D L Martin
Journal:  J Neurochem       Date:  1996-05       Impact factor: 5.372

4.  Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.

Authors:  M E Griffin; D McInerney; A Fraser; A H Johnson; P B Collins; D Owens; G H Tomkin
Journal:  Diabet Med       Date:  1997-09       Impact factor: 4.359

5.  Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis.

Authors:  R C Parslow; P A McKinney; G R Law; A Staines; R Williams; H J Bodansky
Journal:  Diabetologia       Date:  1997-05       Impact factor: 10.122

6.  Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.

Authors:  M Tiedge; S Lortz; J Drinkgern; S Lenzen
Journal:  Diabetes       Date:  1997-11       Impact factor: 9.461

Review 7.  The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus.

Authors:  D R Wegmann
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

8.  Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic beta-cells.

Authors:  A C Loweth; G T Williams; J H Scarpello; N G Morgan
Journal:  Exp Cell Res       Date:  1996-11-25       Impact factor: 3.905

9.  Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.

Authors:  C Davenport; P M Radford; T A Al-Bukhari; M Lai; G F Bottazzo; I Todd
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

10.  Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis.

Authors:  L Casciola-Rosen; F Wigley; A Rosen
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

View more
  27 in total

1.  Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.

Authors:  Suchitra Prasad; Adam P Kohm; Jeffrey S McMahon; Xunrong Luo; Stephen D Miller
Journal:  J Autoimmun       Date:  2012-05-28       Impact factor: 7.094

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 3.  Do post-translational beta cell protein modifications trigger type 1 diabetes?

Authors:  Joachim Størling; Anne Julie Overgaard; Caroline Anna Brorsson; Francesco Piva; Claus Heiner Bang-Berthelsen; Claus Haase; Jørn Nerup; Flemming Pociot
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

4.  An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes.

Authors:  Charlton Martin; Lars Krogvold; Shebani Farik; Satya Amirapu; Fiona Wu; Shiva Reddy; Knut Dahl-Jørgensen
Journal:  Histochem Cell Biol       Date:  2017-02-02       Impact factor: 4.304

Review 5.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

Review 6.  Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.

Authors:  Rebecca Fuhlbrigge; Linda Yip
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 7.  The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery.

Authors:  Karen L Søgaard; Christina Ellervik; Jannet Svensson; Steffen U Thorsen
Journal:  Rev Diabet Stud       Date:  2017-10-10

8.  Post-translational protein modifications in type 1 diabetes: a role for the repair enzyme protein-L-isoaspartate (D-aspartate) O-methyltransferase?

Authors:  A M Wägner; P Cloos; R Bergholdt; P Boissy; T L Andersen; D B Henriksen; C Christiansen; S Christgau; F Pociot; J Nerup
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

9.  Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.

Authors:  K T Coppieters; N Amirian; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2011-05-23       Impact factor: 4.330

10.  HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.

Authors:  R Strollo; P Rizzo; M Spoletini; R Landy; C Hughes; F Ponchel; N Napoli; A Palermo; R Buzzetti; P Pozzilli; A Nissim
Journal:  Diabetologia       Date:  2012-11-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.